1
I.
Development challenge
A. Specific aims of the project
This project aims to promote health conditions to people in the Asian-Pacific Region (RCA) through facilitating and
maximizing the application of Single Photon Emission Computed Tomography (SPECT) and Positron Emission
Tomography (PET) imaging for clinical purposes by transferring knowledge, technologies, and practical
experiences of developed countries to developing countries.
The main goal of the project is to promote and accelerate the use of nuclear imaging technologies in the RCA
Region including Bangladesh, Indonesia, Malaysia, Mongolia, Myanmar, Nepal (to be included after joining
RCA in 2011), Pakistan, Philippines, Thailand, and Vietnam at national levels, and specifically the project will
focus on the following aims:
1) To facilitate the application of SPECT and PET imaging for medical clinics in the Region,
which will have immediate impact on clinical practices;
2) To set-up learning, training and hands-on practice courses, which cover basic pathology with
relevance to functional and molecular nuclear imaging, radiopharmaceutical productions,
imaging and image generation, image analysis and interpretation, and their clinical
applications;
3) To establish a regional network of experts and facilities for nuclear imaging technologies.
The network will provide the channels of communication facilitating nuclear imaging
technologies and exchange of information in the Region;
4) To foster the capability of applications of imaging technologies in research and development
in the Region;
B. Problem analysis and background
With the expansion of life span and consequent demographical shift in the Region, concerns in public health have
moved to diseases that usually affect middle-aged and older people, such as cancer and neurodegenerative diseases
(e.g., Parkinson's disease and related movement disorders, Alzheimer’s disease and other dementias), as well as
existing basic health problems, such as infant death rate, nutritional care, and infectious disease control. According
to Paul Kleihues, M.D., director of IARC and co-editor of the World Cancer Report, cancer has emerged as a major
public health problem in developing countries.
In developed countries, the probability of being diagnosed with cancer is more than twice as high as in developing
countries. However, in developed countries, approximately 50 per cent of cancer patients die of the disease, while in
developing countries, 80 per cent of cancer victims are diagnosed with already on a late-stage of incurable tumors,
pointing to the need for much better detection programs (http://www.who.int/mediacentre/news/releases/2003/
pr27/en/).
Fig.1 Distribution of Global Cancer burden by World Health Organization Region (2008).
From World Cancer Report 2008, WHO
2
Fig. 2 Estimated Global Cancer Burden (Numbers of new cases of
cancer per annum). From World Cancer Report 2008, WHO
Additionally, dementia has become a serious public health problem in developing countries. In 2001, 60.1% of total
population with dementia lived in developing countries, and it is expected to rise up to 64.5% in 2020 and 71.2% in
2040 respectively. The rate of increase in numbers of people with dementia is predicted to be three to four times
higher in developing areas than in developed regions –(Ferri et al., Lancet 2005). Therefore, it is expected that early
detection of cancers and dementia in developing countries will increase life expectancy and improve quality of life
in the Region.
Fig. 3 Number of people with dementia in developed and developing
countries (Ferri et al., Lancet 2005;366:2112-17)
Nuclear imaging technologies enable us to identify functional and molecular changes in the living body, which
precede morphological and structural changes. They make it possible to detect unhealthy conditions earlier,
monitor their progressions, and evaluate their responses to therapeutic measures. Furthermore, with the advent of
these imaging technologies, it has become possible to recognize specific biological processes at molecular levels
non-invasively, serially, and quantitatively for health and disease matters. SPECT/PET imaging technologies have
been widely used for the diagnosis and evaluation of cancerous and neurodegenerative conditions. They play
significant roles in early detection and diagnosis, treatment planning, and monitoring of therapeutic responses of
these diseases.
C. Benefits of the project
The advantages of SPECT/PET imaging technology can be signified by their clinical applications. The higher
spatial and temporal resolutions on PET and further availability in radiopharmaceutical uses enable visualization of
metabolism, perfusion, neuro-transmission, and pathology information other than anatomical changes with the
application of the appropriate radio-tracers. These amplified functions allow its applications in the fields of
Neurology (Epilepsy, dementia, cerebro-vascular disease diagnosis and therapeutic effect evaluations), Oncology
(Cancer screening, staging, recurrence detection and re-staging) and Cardiology (Coronary artery disease,
myocardial viability determination).
Recently, there are growing numbers of nuclear SPECT and PET imaging devices and facilities in developing
countries in the region, especially in the South-East Asian region, which possibly could grow exponentially within
the next 5-10 years. However, these countries suffer from a lack of imaging technologies and their application
techniques, qualified personnel, and regional/international cooperative activities, which prevent them from efficient
3
and maximized utilization of imaging devices and facilities both for clinical and research purposes. Therefore, this
project aims to facilitate and maximize the application of SPECT and PET imaging for clinical sciences by
transferring knowledge, technologies, and practical experiences of developed countries to developing countries,
which will reduce the gaps in knowledge, technologies, and human resources between developing and developed
countries and help realize a harmonized progression of nuclear medicine sciences in the Region. Furthermore, this
project will stimulate demands for nuclear imaging devices and facilities and facilitate their early establishment and
practical applications in the countries that currently have limited infrastructure.
II.
Strategy
Korea and Australia possess a high level of well qualified individuals and correspondingly well established
equipment used for nuclear medicine, and will provide human resources and training infrastructures in this project.
In case of Korea, the manpower in the field of nuclear medicine consists of 147 nuclear medicine physicians, 817
nuclear medicine technologists and 113 nuclear scientists. Additionally, there are 127 PET machines and 207
SPECT machines throughout the nation. With the advent of FDG (fluorodeoxyglucose), PET is widely used in
neurology, cardiology, and oncology and became essential in medical practices. About 248,000 PET studies were
conducted in 2008, and 90% of them were related to oncology. Cardiology and neurology are the main applications
of SPECT. A total of 15,500 brain perfusion SPECT and 78,000 myocardial perfusion SPECT were performed in
2008. As PET and SPECT machines can visualize to cellular and molecular levels, its utilization is growing in
medical practices as well as researches. Recently, the Ministry of Education, Science and Technology (MEST) has
established a comprehensive plan to promote SPECT and PET technologies in other countries. Supported by Korean
governmental grants, transferring the nuclear medicine technology will improve the quality of medical practices and
enrich the research capacities in the Region.
Technologies will be transferred through the project using strategies such as train-the-trainees, on-site regional
workshops, hands-on practices, interactive and customized training courses, and intra/inter-regional networking,
including pathology that is relevant to nuclear imaging, radio-pharmaceutical production, image acquisition and
reconstruction, image analysis/interpretation and clinical applications, neurochemistry imaging technologies, and
molecular oncologic imaging technologies. This will contribute to the progress of clinical sciences by augmenting
the application of imaging technologies and maximizing the use of imaging instruments and facilities and enhancing
science capabilities in the Region.
The RCA (Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science
and Technology for Asia and the Pacific) consists of 17 Member States and has been recognized as an effective
partner in providing nuclear technologies that enhance socio-economic wellbeing and contribute to sustainable
development in the region. RCA Regional Office (RCARO) on behalf of RCA, has promoted the peaceful uses of
nuclear technology to assist in addressing regional and national needs as a part of its activities.
This project has been initiated by RCARO on behalf of RCA and was approved as a partnership project with UNDP
at the RCA General Conference Meeting held in September 2009 for implementation. RCARO is responsible for
overall management and implementation arrangement of the project as well as provision of matching funds. Further,
as a project secretariat, RCARO will invite participants from Bangladesh, Indonesia, Malaysia, Myanmar, Mongolia,
Nepal (to be included after joining RCA in 2011), Pakistan, Philippines, Republic of Korea, Singapore,
Thailand, and Vietnam.
RCA Regional Office will lead the project with the support of RCA Member States and work in conjunction with
Seoul National University, Seoul, Korea, which is the project leading country coordinator and the leading
technology provider. The Department of Nuclear Medicine of Seoul National University, which has been designated
as IAEA Collaborating Center for Nuclear Medicine and Molecular Imaging in December 2004, is dedicated to
research, educate and train nuclear medicine technologies and their clinical applications, covering project work
plans thoroughly. This project will be also conducted in collaboration with IAEA/RCA, ARCCNM (Asian Regional
Cooperative Council for Nuclear Medicine), ASNM (Asian School of Nuclear Medicine), and local societies of
nuclear medicine.
4
The specific roles of each institute/stake holder are as following:
A. RCARO/KAERI





Management of the project
Technological needs feedback
Evaluation of the project outcome
Establishing strategies for sustainability
Providing matching funds




Technology transfer via training courses and workshops
Providing human resources and training infrastructures
Establishing networks
Establishing strategies for sustainability





Participating in training protocol development
Reporting regional status of technology and technology needs feedback
Assisting in selecting appropriate trainees
On-site application and dissemination, and report of the outcome at national level
Establishing networks at national level
B. Main technology providers (Korea)
C. Role of recipients and Beneficiaries
Fig. 4 Implementation strategy of the project
5
III.
Results
Intended Outcome: With the successful accomplishment of the project, it is expected that the levels of
nuclear imaging and its application capabilities will be enhanced in participating countries from RCA
region in terms of knowledge (up to 80% of developed countries), technology (up to 70%), and human
resources (up to 60%).
Outcome indicators: Improvement in MDG indicators for partner countries.
Partnership Strategy: UNDP SU/SSC and MEST will enlist the expertise of Korean institutions and
other developing country institutions. SU/SSC will also bring in the collaboration of specialized UN Agen
cies for the projects that relate to their area of expertise.
Project Title and ID: Promoting and Accelerating Nuclear SPECT/PET Imaging Technologies in the Region
Project ID:
Output Targets
Enhancement of
basic capacity
of SPECT/PET
imaging science
and technology
in 8 participating
countries
1.1. Capacity
upgrade of
basic
background
knowledge of
SPECT/PET
imaging for
selected
participants
(In 2011-12)
1.1.1. Developments of training course
protocol (designing: curricula, teaching
materials and teacher training
programmes)
1.1.2. Basic training on SPECT/PET imaging
science and technology
1.1.3. “Train-the-Trainers” Courses
-Basic path physiology related to
SPECT/PET imaging
-Basic principles of SPECT/PET
instrumentation
-Radiopharmaceutical production
-Image acquisition and reconstruction
-Image analysis and interpretation
1.1.4. On-site regional workshops
1.1.5. Hands-on practices
Facilitation of
Nuclear
imaging-training
including
radiochemistry
and medical
physics in 8
Participating
countries
2.1 Build-up of
practices and
skills for
selected
participants
using
SPECT/PET
equipment and
facilities
(in 2012-13)
Training on SPECT/PET imaging application
technologies for medical clinics(inc.
neurodegenerative and oncologic
disorders)
Hands-on practices
-SPECT/PET management system
-Clinical applications
-Reporting system of nuclear imaging
results
“On-site regional workshops
2.1.5 Evaluation of Training Courses
MEST, UNDP
SU/SSC,
RCARO/KAE
RI, Korea
SNU,
ARCCNM
ASNM
Participating
countries
Consultations
Training
Publications
Travel
Resource
people
Miscellaneous
Establishing
network of
experts and
facilities for
nuclear imaging
technologies
3.1. Intra/interregional
networking
establishment
(In 2013)
3.1.1. Establishing Intra/inter-regional
networks
3.1.2. Establishing expert networks
3.1.3. Interactive web-based protocols and
systems
3.1.4. Networking activity reports
3.1.5. Establishing strategies for sustainability
Consultations
Publications
Travel
Resource
people
Miscellaneous
$50,000
Completing and
evaluating
project
4.1. Review and
valuation of
the project
(In 2013)
4.1.1. Review meetings
4.1.2. In-depth feedback of training courses
4.1.3. Final Project evaluation
MEST, UNDP
SU/SSC,
RCARO/KAE
RI, Korea
SNU,
ARCCNM
ASNM
Participating
countries
MEST, UNDP
SU/SSC,
RCARO ?KA
ERI, Korea
SNU,
ARCCNM
ASNM
Participating
countries
Total
Indicative activities
Collaboratin
g partners
MEST, UNDP
SU/SSC,
RCARO/KAE
RI,
Korea SNU,
ARCCNM
ASNM
Participating
countries
Intended outputs
Inputs
Consultations
Training
Publications
Resource
people
Travel
Miscellaneous
$150,000
$250,000
Training
Workshops
$50,000
$300,000
From UNDP
SU/SSC);
$200,000
from RCARO)
7% GMS
Total + GMS
*The indicative activities are subject to the circumstances of the progress of the project.
6
Annex 1. In-kind Contributions
Estimation of In-Kind Contributions by SNU (December 2010-December 2013)
Type of contribution
Description of item
Estimation
1
Personnel cost
Work of project manager, assistant,
accountant, expert, consultant, lecturer
and volunteers *
42 person for 36
months= $ 226,800
2
Books, leaflets or any other printed
material
$ 4,000
3
Author work for creation of
teaching protocol and
materials
Use of equipments
$ 20,000
4
Use of facility
Use of nuclear medicine equipments and
workstations **
Rent for meeting hall/room for training and
class rooms
5
Supplies and material
Supplies for offices and laboratories
$ 50,000
6
Use of software
Cost of software license for period of use
$ 12,000
7
Communication
Phone, internet and post
$ 1,000
8
Use of vehicles/fuel
Cost of vehicle rent/fuel
$ 3,000
Total
$ 3,000*6=$ 18,000
$ 334,800
1) Major facilities and equipments contributed by SNU
- Cyclotron
- Full service radiopharmacy (including hot cells and chemistry laboratory)
- Gamma camera
- PET/CT
- PET/MR
- SPECT/CT
- Small animal PET/CT
- Small animal SPECT/CT
- Workstations for image analysis
2) Staff from SNU
- Sang Eun Kim, M.D., Ph.D.
- June Key Chung, M.D., Ph.D.
- Dong Soo Lee, M.D., Ph.D.
- Won Woo Lee, M.D., Ph.D.
- Keon Wook Kang, M.D., Ph.D.
- Jae Min Jeong, Ph.D.
- Byung Chul Lee, Ph.D.
- Yun Sang Lee, Ph.D.
- Yu Kyeong Kim, M.D., Ph.D.
- Jin Chul Paeng, M.D., Ph.D.
- Ho Young Lee, M.D., Ph.D.
- So Won Oh, M.D.
3) Sungkyunkwan University School of Medicine (Department of Nuclear Medicine)
- Joon Young Choi, M.D., Ph.D.
4) Administrative Services
7
-
SNU R&DB FOUNDATION
Estimation of In-Kind Contributions by Participating Member States
(December 2010-December 2013)
(In USD)
Type of Contributions
Member States
Estimation
1
Participation of courses and kick-off
meeting and annual meetings
Participating Member States
12 persons x $2,000 x 11
= $264,000
2
Project assistance by assisting staff
Participating Member States
12 x 3 persons x $1,000
x 6 months = $216,000
3
Use of facilities for meetings and
training course, etc. at national level
Participating Member States
12 countries x $5,000 x3
= $180,000
4
Operation of National Project Teams
Participating Member States
12 x 3 persons x $1,000
x 6 months = $216,000
Total
$ 876,000
(Remarks) Estimation can be revisited subject to the situation of the participating Member States. Annual
estimation for in-kind contribution will be agreed at the kick-off meeting for 2011 by electronic
communication.
All the coordinating agencies of the participating Member States (MSs), through the National Project
Coordinators (NPCs) in Member States, will provide personnel, equipments, facilities and their
expertise to accomplish the Project as the In-Kind Contributions as follows;
- More than three assisting staffs including the NPCs for the project works
- Assisting staffs of the General Affairs Division, Accounting Division, International Cooperation Division, Public Information Division, etc. to support the implementation of the
project on a national level
- Facilities for meetings, training course, annual meetings, etc.
- Operation of the National Project Teams (NPTs) for implementation of the project at national
level according to the Work Plan, under the guidance of the Local National Project
Coordinator (NPC) and providing feedback and advice to the Local NPC on matters relevant
to project implementation and achievement of project objectives
The national project coordinating agencies of the Participating Member States are as follows;
-
Republic of Korea (MEST: Ministry of Education, Science and Technology)
Singapore (SGH: Singapore General Hospital)
Bangladesh (INMU: Institute of Nuclear Medicine and Ultrasound)
Indonesia (BATAN: National Atomic Energy Agency)
Malaysia (MINT: Malaysian Institute of Nuclear Technology, Research)
Mongolia (Department of Nuclear Medicine)
Myanmar (DAE: Department of Atomic Energy)
Nepal : to be included after joining RCA in 2011
Pakistan (KIRAN : Karachi Institute of Radiotherapy and Nuclear Medicine)
Philippine (PNRI: Philippine Nuclear Research Institute)
Thailand (Chulabhorn Hospital)
Vietnam (VAEC: Vietnam Atomic Energy Commission)
8
Annex 2. Participating Countries and Representatives
No.
Country
Name
1
Bangladesh
Raihan Hussain
2
Indonesia
A. Hussein S.
Kartamihardja
3
Malaysia
Boon-Nang Lee
4
Mongolia
Sereegotov
Erdenechimeg
5
Myanmar
6
Nepal
Ram Krishna
Shrestha
7
Pakistan
Dr. Kashif Niaz
8
Philippines
Emerita Andres
Barrenechea
9
Republic
Korea
10
Singapore
S. Somanesan
11
Thailand
Chanisa
Chotipanich,
M.D.
12
Vietnam
Mai Trong Khoa
Organization and Contact Information
Principal Medical Officer
Institute of Nuclear Medicine and Ultrasound,
Dhaka BSMMU Campus, Shahbag, Dhaka
Ph: 880-2-8621697
raihan_h@yahoo.com
Department of Nuclear Medicine, School of Medicine,
Padjadjaran University
Bandung, Indonesia
husseinsk@yahoo.com
husseinsundawa@yahoo.com
Head, Department of Nuclear Medicine,
Hospital Kuala Lumpur, Malaysia
bnlee@hkl.moh.gov.my
of
Sang Eun Kim
Department of Nuclear Medicine, First State Central
Hospital of national Medical University
Erkhuu, Mongolia
sereegotov@yahoo.com
To be informed by Myanmar RCA National
Representative
President-SNM, Nepal
Gamma Camera Imaging Centre/Metro Radiology and
Imaging Centre
Kathmandu, Nepal
Rkshrestha7@hotmail.com
Senior Medical Officer, KIRAN, Karachi
Karachi Institute of Radiotherapy and Nuclear
Medicine (KIRAN)
Ph: (office) 0092 21 992 61601-4/Extension 286
kiran@ntc.net.pk
Department of Nuclear Medicine, Veterans Memorial
Medical Centre
Quezon City 1100, Philippines
emie-ab@hotmail.com
Department of Nuclear Medicine, Seoul National
University Bundang Hospital,
Seoul National University College of Medicine
Seoul, Republic of Korea
kse@snu.ac.kr
Senior Principal Radiation Physicist
Dept of Nuclear Medicine & PET
Operations & QA Manager, Cyclotron facility, PTPL
Singapore General Hospital
Ph: 6326 5667
gnmss@sgh.com.sg
National Cyclotron and PET Center, Chulabhorn Hospital
chanisa.ja@gmail.com
Department of Nuclear Medicine, Hanoi Medical
University, Bach Mai University Hospital
Hanoi, Vietnam
khoa-mt@hn.vnn.vn
9
*The participants are subject to change by the circumstances of RCA Member Countries.
Annex 3. Annual Work Plan
Expected Outputs
1) This project, by enhancing the nuclear SPECT/PET imaging technologies in the Region, will
contribute to the progress of clinical sciences including management of patients with oncologic and
neurologic disorders, which will have immediate impact on clinical practices. Furthermore, this will
help reduce total costs of health care services in participating developing countries of the project in
the RCA Region
2) This project, by facilitating nuclear imaging-related sciences including radiochemistry and medical
physics in the Region, will augment basic science and technology for clinical applications and
maximize the use of imaging devices and facilities. Furthermore, this project will provide the Region
with opportunities to widen boundaries of nuclear medicine and molecular imaging;
3) This project, by addressing principles of nuclear imaging technologies comprehensively, will enrich
basic and applied science capabilities in the Region, which will make economic and social profits in
the long run.
Planned Activities
1. Development of training course protocol (Interactive and customized training courses)
2. “Train-the-Trainers” courses
•
Basic path physiology related to SPECT/PET imaging
•
Basic principles of SPECT/PET instrumentation
•
Radiopharmaceutical production
•
Image acquisition and reconstruction
•
Image analysis and interpretation
3. On-site regional workshops
4. Hands-on practices
•
SPECT/PET management system
•
Clinical applications
•
Reporting system of nuclear imaging results
5. Intra/inter-regional networking (including local and central offices)
•
Establishment of intra/inter-regional networks
•
Establishment of Expert networks
•
Development of interactive web-based protocols and systems
6. Interim and final evaluation and report/feedback
Timeframe
Jan - Mar
Apr - Jun
Jul - Sep
Oct - Dec
2011
Expert meetings
for training course
protocol
Completion of
protocols
Training courses
#1,2 (4 wks each)
Training courses
#3,4 (4 wks each)
2012
Training course #5
(4 wks)
Interim evaluation
and report
On-site regional
workshop #1
Hands-on practices
#1 (short-term)
Hands-on practices
#2 (short-term)
On-site regional
workshop #2
Intra/inter-regional
networking
(including local
and central offices
setup)
Final evaluation
and report
2013
10
Responsible Party
Activity
Responsible party
Development of training course protocol
RCARO, Korea SNU, Singapore
“Train-the-Trainers” courses
Basic path physiology
Basic principles of instrumentation
Radiopharmaceutical production
Image acquisition and reconstruction
Image analysis and interpretation
Korea SNU, Singapore
On-site regional workshops
Korea SNU
Hands-on practices
SPECT/PET management system
Clinical applications
Reporting system of nuclear imaging results
Korea SNU
Intra/inter-regional networking
Intra/inter-regional networks
Expert networks
Interactive web-based protocols and systems
RCARO, Korea SNU, Singapore
Interim and final evaluation and report/feedback
RCARO, Korea SNU, Singapore
Monitoring and Evaluation
Performance indicators
Conduct of expert meeting for
establishing training course protocols
Means of verification
Training course protocol reports
Training course reports
Conduct of training courses of nuclear
imaging
Test of accomplishments
Questionnaires for feedback
Conduct of establishing technology
networks
Networking activity reports
Workshop proceedings and reports
Conduct of regional workshops on
nuclear imaging
Test of accomplishments
Questionnaires for feedback
Percent increase in medical radioisotopes produced
and consumed
Conduct of knowledge/technology
transferring
Percent increase in number of SPECT/PET
examinations
Percent increase in imaging device operation time
Quality assurance data
Conduct of enrichment of human
resources
Percent increase in number of nuclear medicine
personnel
11
Annual Work Plan Year: 2011
EXPECTED RESULTS
And baseline, indicators including annual
targets
PLANNED ACTIVITIES
List activity results and associated
actions
TIMEFRAME
Q1
Kick Off meeting
Developments of training
course protocol (designing:
curricula, teaching materials
and teacher training
programmes
Q2
Q3
RESPONSIBLE PARTY
Q4
X
X
UNDP/RCARO/SNU
X
UNDP/RCARO/SNU
PLANNED BUDGET
Funding Source
Budget Description
Amount
UNDP
Travel Expenses
and etc.
$38,000
UNDP
/RCARO/KAERI
Protocol meeting
including travel
expenses
$17,000
RCARO?KAERI
Travel expenses:
$33,000
Materials and
goods: $5,600
Teaching materials
and fees: $13,400
$52,000
Travel expenses:
$17,000
Materials and
goods: 5,000
Teaching materials
and fees: $18,000
$40,000
Basic training on SPECT/PET
imaging science and
technology (“Train-theTrainers”):
Enhancement of basic capacity of  Basic pathophysiology related
SPECT/PET imaging science and
to SPECT/PET imaging
technology in 8 participating
 Basic principles of SPECT/PET
countries
instrumentation
X
UNDP/RCARO/SNU
 Radiopharmaceutical
production
Target:
 Image acquisition and
Capacity upgrade of basic
reconstruction
background knowledge of

Image analysis and
SPECT/PET imaging for selected
interpretation
participants
On-site regional training:
 Basic pathophysiology related
to SPECT/PET imaging
 Basic principles of SPECT/PET
instrumentation
 Neurochemistry imaging
technologies
 Molecular oncologic imaging
technologies
Annual Review Meeting
Project Monitoring
X
X
X
X
UNDP/RCARO/SNU
RCARO?KAERI
X
UNDP/RCARO/SNU
UNDP
X
UNDP/RCARO/SNU
UNDP
Travel Expenses
and etc.
Publication, travel
expenses and etc.
$38,000
$15,000
12
Annual Work Plan Year: 2012
EXPECTED RESULTS
And baseline, indicators including annual
targets
PLANNED ACTIVITIES
List activity results and associated
actions
TIMEFRAME
Q1
Q2
Q3
PLANNED BUDGET
Q4
RESPONSIBLE PARTY
Funding Source
Budget Description
Amount
UNDP
Travel expenses:
$35,000
Materials and goods:
$7,000
Teaching materials
and fees: $16,000
$58,000
Training on SPECT/PET
imaging application
technologies for medical
clinics (Hands-on practices):
Facilitation of nuclear imagingtraining including radiochemistry
and medical physics in 8
Participating countries
Target:
Build-up of practices and skills
for selected participants using
SPECT/PET equipment and
facilities
 SPECT/PET management
system
 Clinical applications
 Neurochemistry imaging
applications
 Molecular oncologic imaging
applications
 Reporting system of nuclear
imaging results
X
UNDP/RCARO/SNU
On-site regional training:
 Clinical applications
 Neurochemistry imaging
applications
 Molecular oncologic imaging
applications
X
Annual Review Meeting
Project Monitoring
X
X
X
UNDP/RCARO/SNU
UNDP
X
UNDP/RCARO/SNU
RCARO/KAERI
X
UNDP/RCARO/SNU
RCARO/KAERI
Travel expenses:
$17,500
Materials and goods:
$6,000
Teaching materials
and fees: $18,500
Annual Evaluation
meeting including
travel expenses
Publication, travel
expenses and etc.
$42,000
$35,000
$15,000
13
Annual Work Plan Year: 2013
EXPECTED RESULTS
And baseline, indicators including annual
targets
Enhancement of basic capacity of
SPECT/PET imaging science and
technology in 8 participating
countries
Target:
Capacity upgrade of basic
background knowledge of
SPECT/PET imaging for selected
participants
Facilitation of nuclear imagingtraining including radiochemistry
and medical physics in 8
Participating countries
Target:
Build-up of practices and skills for
selected participants using
SPECT/PET equipment and
facilities
Establishing network of experts
and facilities for nuclear imaging
technologies
Target:
Intra/inter-regional networking
establishment
PLANNED ACTIVITIES
List activity results and associated
actions
Hands-on practices (II):
 Radiopharmaceutical
production
 Image acquisition and
reconstruction
 Image analysis and
interpretation
TIMEFRAME
Q1
Q2
Q3
PLANNED BUDGET
Q4
X
UNDP/RCARO/SNU
On-site regional training:
 Clinical applications
 Neurochemistry imaging
applications
 Molecular oncologic
imaging applications
Establishing Intra/interregional networks
Establishing expert networks
Interactive web-based
protocols and systems
Establishing strategies for
sustainability
RESPONSIBLE PARTY
X
UNDP RCARO/SNU
X
X
UNDP/RCARO/SNU
X
X
UNDP/ /RCARO/SNU
X
X
UNDPRCARO/SNU
X
X
UNDP/RCARO/SNU
Funding Source
Budget Description
Amount
RCARO/KAERI
Travel expenses:
$21,000
Materials and goods:
$5,000
Teaching materials
and fees: $9,000
$35,000
UNDP
Travel expenses:
$16,500
Materials and goods:
$5,000
Teaching materials
and fees: $18,500
$40,000
UNDP
Web-system
development:
$10,000
Expert networks/
sustainability
strategies:
$10,000
$20,000
Completing and evaluating project
Target:
Review meetings convened and
evaluation conducted at end of
project
Final Evaluation Meeting:
 In-depth feedback of
training courses
 Final project evaluation
Project Monitoring
X
X
X
X
UNDP/RCARO/SNU
UNDP
Final evaluation
Meeting including
travel expenses
$40,000
X
UNDP/RCARO/SNU
RCARO/KAERI
Publication, travel
expenses and etc.
$15,000
14
Annex 4: Framework for Project Implementation
MEST
RCA NRM (1)
UNDP-SU/SSC
RCARO SAC (2)
DIR. RCARO (3)
(NPD)
PLCC (4)
NPC(5)
NPT(6)
(1) National RCA Representatives Meetings
(2) RCARO Standing Advisory Committee
(3) Director, RCARO (National Project Director)
(4) Project Lead Country Coordinator
(5) National Project Coordinator
(6) National Project Team
15
Annex 5: Roles and Responsibilities
1. RCA NRM (National RCA Representatives Meetings)
(a) to determine RCA programme of activities including RCARO initiated projects and to
establish priorities
(b) to consider and approve the RCA-UPDP project on behalf of RCA
(c) to review the implementation of the RCA-UNDP project on behalf of RCA
2. RCARO SAC (Standing Advisory Committee)
(a) to give advice, on behalf of the RCA Member States, on the Project Concept Paper prepared by
RCARO to submit to the RCA NRM for their consideration. The SAC will also give advice, on
behalf of the Member States, on the Project Contract Document to be submitted to the UNDP.
* RCARO SAC (Chair: RCA NRM Chair, Members: currently the National RCA Representatives of
Indonesia, Philippines, China, Republic of Republic of Korea, RCA Focal Person of IAEA)
3. Director, RCARO
(a) The Director, RCARO will prepare a Concept Paper of this RCA-UNDP Project according to the
RCA format and submit it to SAC together with a justification for the use of the fast-track
mechanism in processing this project considering that the RCA standard approval mechanism
will not be appropriate to follow;
(b) On acceptance of the use of the fast track option by the SAC, the Director of RCARO, the SAC,
and if appropriate the PLCC, will jointly prepare a Project Proposal (Project Contract Document)
with explanatory text complemented by any necessary additional materials, according to the
UNDP format, and promptly distribute them to NRs for consideration and comment by a due
date.
(c) The Director, RCARO will conclude the Project Contract with the donors (UNDP and MEST) in
due course and time.
(d) The Director, RCARO will serve as a National Project Director of RCA-UNDP Project.
(e) With regard to other TORs for the Director, RCARO, please refer Annex 6.
4. NPC (National Project Coordinator)
(a) The NPCs will be appointed from RCARO, in consultation with National RCA Representatives
(NRs) of participating member states.
(b) For the TORs of the NPC, please refer Annex 7.
5. PLCC (Project Lead Country Coordinator)
(a) to provide leadership for the efficient and effective planning, designing, preparation and
implementation of the project to achieve its stated aims and objectives
(b) to coordinate with the NPC in drafting detailed annual work plans based on the Project
Document, in consultation with the National Project Coordinators from the participating
Member States
(b) to ensure that the project is implemented in compliance with the RCA strategic
objectives as well as the requirements of donors
(c) to correspond regularly with the NPC, to discuss matters associated with the project
implementation, monitoring and evaluation,
(d) to monitor the implementation of the projects and progress in participating countries
through reports of and correspondence with National Project Coordinators,
(e) to coordinate with NPC in submitting quarterly a report on the progress of the project
with updated and detailed work plan to the donors, when necessary,
(f) to participate in project related meetings (e.g. project assessment meetings) as required
and provide leadership for the successful conduct of the meeting;
16
6. NPT (National Project Team) in the selected countries
(a) National Project Teams will be responsible for implementation of the project at national
level according to the Work Plan, under the guidance of the Local National Project
Coordinator (NPC) and providing feedback and advice to the Local NPC on matters
relevant to project implementation and achievement of project objectives.
17
Annex 6. Terms of Reference of Director of RCARO (NPD)
BACKGROUND
Director of RCARO (NPD) will be responsible and accountable for the overall management,
implementation and monitoring of the project according to UNDP’S National Execution
requirements, and for the overall success of the project. As such, he/she will be responsible for
strategy set-up, the quality, efficient and timely implementation of the project according to the work
plan, for the sound financial management and for the achievement of quality and timely project
outputs and impacts, good coordination with various counterparts. He/she will provide guidance and
support to the NPC throughout the project implementation.
DUTIES
Project direction
Director of RCARO (NPD) has the overall responsibility for appropriate management of the funds,
achievement of the planned outputs in a timely fashion and at the highest quality.
Ensure and approve punctual delivery of all project work plans, budget revisions and, where
necessary, project revisions, and that all the auditing requirements are met as specified in the project
document and in the UNDP Programming Manual;
Ensure human and financial resources allocated for project activities are consistent with approved
work plans in contributing to the achievement of the planned outputs;
Certify financial reports including reports on the advances and reports on the annual disbursements;
In consultation with the Executing Agency, approve terms of references, selection of the NPC, and
other project staff and of the key experts/contractors;
Approve procurement actions;
Prior to financial settlement, approve quality and relevance of reports produced by consultants;
Project monitoring
Report to the UNDP on the use of the project resources and achievement of the project outputs;
Approve/certify; bi-annual progress report and financial report (30 June), and annual report(30
December);
Ensure all documentation is complete, certified.
18
Annex 7. Terms of Reference for the National Project Coordinator (NPC)
General Job Description
The NPC will be responsible for facilitating and coordinating including information capture, exchange
and networking, between a wide range of participating countries in the Project including government
officials, scientists, non-governmental organizations and the public at large. He/she will work closely
with project implementation focal points e.g. PLCC, NPT and international research institutes, and
shall work under the supervision of the DIRECTOR OF RCARO within the Project Implementing
Agency (RCARO)
Duties
The NPC assumes the direct responsibility for the preparation of:
(ⅰ) Annual and quarterly work plans and budgets of the Project
(ⅱ) Biannual financial reports and biannual progress reports, and annual programme reports
(ⅲ) Terms of Reference for international and national consultants and local experts
The NPC functions his/her roles and responsibilities in close cooperation with the PLCC.
The NPC also assumes the direct responsibility for the pre-selection of international and national
consultants and local experts, to be designated by National Project Director, in consultation with the
Project implementation Coordinators and other relevant project agencies. He/she will also be
responsible for providing guidance and support, and also for monitoring the work of consultants, in
order to ensure quality and timely production of final reports.
- Assist the DIRECTOR OF RCARO in ensuring full coordination of national inputs; and
- To provide leadership for implementation of the projects at national level
- To provide information on the progress of the projects to the National RCA
Representative of his country on a regular basis
- To provide information through its National RCA Representative to the Project Lead
Country Coordinator on national status and needs of the ongoing projects, and
information needed for project design and for drafting the detailed project proposals
when requested by Project Lead Country Coordinator
- To establish a National Project Team with the approval of the National RCA
Representative, and assign responsibilities for each member
- To recommend to its National RCA Representative the members of the National Project
Teams who could be nominated for RCA-UNDP Project related events and activities
and ensure their timely nomination
- To prepare Work Plans for implementation of the project at national level (National
Work Plans), and monitor the progress of implementation through regular
consultations with the Project Team
- To submit a progress report of project activities to the PLCC through its National RCA
Representative as requested
- To report on the progress of the projects, and future project requirements at the
Project Related Meetings
19
Annex 8. The legal relationship between the RCA Regional Office (RCARO) and
the Korea Atomic Energy Research Institute (KAERI)
The following is included as an annex to the Arrangement on the cooperative project signed on 28
December and 27 December, 2010 respectively between UNDP and RCARO.
1. The Article 3 of the 83rd Order of the Ministry of Education, Science and Technology,
Republic of Korea, the regulation on the establishment and promotion of RCARO revised on
28 July, 2008 (hereinafter “MEST Regulation”), confirms the following.
- RCARO is established within the premises of KAERI and fully supported by the president
of KAERI for its cooperative activities with the Asian-Pacific Member States, while being
allowed independence in organization, personnel management and accounting, etc.
2. Based upon the Article of the MEST Regulation, the Provision 2 of the Management
Regulation of RCARO by KAERI (hereinafter “KAERI Regulation”) stipulates the following:
- Clause 1 stipulates that RCARO is established and operated as an interim organization
grounded on the provision 3 and clause 3 of the KAERI’s Regulation on Organizational
Structure;
- Clause 2 stipulates that the duration of establishment and operation of RCARO in KAERI
is up until its launch as an international organization according to the “Regional
Cooperative Agreement for Research, Development, and Training related to Nuclear
Science and Technology” (hereinafter “Agreement”); and,
- Clause 3 stipulates that KAERI empowers RCARO to be independent in organization,
personnel management and accounting, etc. according to the MEST Regulation so that
RCARO can implement RCA cooperative activities under the Agreement.
3. In accordance with the above domestic regulations legally effective in Republic of Korea,
RCARO, though it is not an independent legal entity, is allowed autonomy by Korean
government and KAERI as an interim organization under KAERI for the implementation of
projects for the 17 RCA Member States.
4. For implementing and accounting the cooperative project between RCARO and UNDP,
financial transactions between the two parties are done via the foreign currency bank
account under the name of the president of KAERI, which signature is identical to the legal
seal as appeared below.
April, 2011
______________________
Mr. MUN-KI LEE, Ph.D.
Director of RCARO
______________________
Mr. YOUN-HO JUNG, Ph.D.
President of KAERI